secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001213900-24-018231
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

180 Life Sciences appoints Blair Jordan as independent director; compensation includes deferred cash fees
--------------------------------------------------------------------------------

- Blair Jordan appointed as Class II director effective Feb 28, 2024; serves as Lead Independent Director and Chair of Strategy & Alternatives Committee.
- Annual cash compensation: $40K retainer + $10K committee chair + $15K lead director; initial payment $7,500.
- Half of cash compensation accrued until company raises $1M aggregate from any source.
- Jordan is independent under Nasdaq rules; serves on Audit, Compensation, Nominating and Governance, and Risk committees.
- Jordan previously served as interim CEO/CFO of Ascent Industries, which obtained creditor protection under CCAA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000121390024018231/0001213900-24-018231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000121390024018231/ea0200917-8k_180life.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-018231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer